Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
04 2023
Historique:
received: 13 04 2022
accepted: 25 07 2022
medline: 20 4 2023
pubmed: 7 10 2022
entrez: 6 10 2022
Statut: ppublish

Résumé

Interstitial lung disease (ILD) has been described as a possible pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV), mainly granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Aim of this cross-sectional Italian national study was to describe demographic, clinical and serological profile of ILD related to MPA and GPA and investigate possible correlations between radiologic patterns of ILD and vasculitis features. We enrolled 95 consecutive patients with AAV-ILD, 56 affected by MPA (58.9%) and 39 by GPA (41.1%). NSIP was the most frequently detected ILD pattern, observed in c-ANCA patients in 60.9% of cases, followed by UIP pattern mainly observed in p-ANCA patients (47.7%, p=0.03). ILD represented the first clinical manifestation, preceding vasculitis diagnosis in 22.1% of cases and, globally, ILD was already detectable at AAV diagnosis in 66.3% of patients. The diagnosis of ILD preceded that of AAV in 85.7% of p-ANCA positive-patients, while only one patient with c-ANCA developed ILD before AAV (p= 0.039). Multivariate analysis confirmed the correlation of UIP pattern with p-ANCA-positivity and a diagnosis of ILD before AAV, also when adjusted for age and sex. Our study confirms that UIP is a frequent pattern of lung disease in AAVILD patients. Our results also suggest that ILD can represent an early complication of AAV but also occur in the course of the disease, suggesting the need of a careful evaluation by both pulmonologist and rheumatologist to achieve an early diagnosis. Further prospective studies are needed to define ILD prevalence and evolution in AAV patients.

Identifiants

pubmed: 36200955
pii: 18659
doi: 10.55563/clinexprheumatol/xu4hmh
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0
Myeloblastin EC 3.4.21.76
Peroxidase EC 1.11.1.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-828

Investigateurs

Franco Schiavon (F)
Emiliano Marasco (E)
Angelica Gattamelata (A)
Roberto Bortolotti (R)
Danilo Malandrino (D)
Beatrice Maranini (B)

Auteurs

Andreina Manfredi (A)

Rheumatology Unit, Azienda Ospedaliera Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy. andreina.manfredi@gmail.com.

Giulia Cassone (G)

Rheumatology Unit, Azienda Ospedaliera Policlinico di Modena, University of Modena and Reggio Emilia, Modena, and Clinical and Experimental Medicine, PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Raffaella Izzo (R)

Rheumatology Unit, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Italy.

Gloria Dallagiacoma (G)

Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Italy.

Mara Felicetti (M)

Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, and Rheumatology Unit, Santa Chiara Hospital, Trento, Italy.

Adriana Cariddi (A)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milano, Italy.

Alvise Berti (A)

Rheumatology Unit, Santa Chiara Hospital, Trento, Italy.

Alessandro Giollo (A)

Rheumatology Section, Department of Medicine, University of Verona, and Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, Italy.

Carlotta Nannini (C)

Division of Rheumatology, Prato Hospital, Prato, Italy.

Silvano Bettio (S)

General Medicine Unit 1, Regional Centre for Rare Immunological and Rheumatological Diseases, Ca' Foncello, University Hospital of Treviso, Italy.

Sara Monti (S)

Department of Rheumatology, IRCCS Policlinico S. Matteo Fondazione, University of Pavia, Italy.

Edoardo Conticini (E)

Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy.

Marcello Govoni (M)

Rheumatology Unit, S. Anna Hospital (AZOU) Ferrara, Department of Medical Sciences, University of Ferrara, Italy.

Luca Quartuccio (L)

Rheumatology Clinic, Department of Medicine, University of Udine, ASU FC, Udine, Italy.

Lorenza Maria Argolini (LM)

Division of Rheumatology, ASST Gaetano Pini, Milan, Italy.

Shaniko Kaleci (S)

Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Modena, Italy.

Giacomo Emmi (G)

Department of Experimental and Clinical Medicine, University of Firenze, Italy.

Christian Dejaco (C)

Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Italy, and Department of Rheumatology, Medical University Graz, Austria.

Roberto Padoan (R)

Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, Italy.

Lorenzo Dagna (L)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milano, Italy.

Maurizio Rossini (M)

Rheumatology Section, Department of Medicine, University of Verona, Italy.

Fabrizio Cantini (F)

Division of Rheumatology, Prato Hospital, Prato, Italy.

Carlomaurizio Montecucco (C)

Department of Rheumatology, IRCCS Policlinico S. Matteo Fondazione, University of Pavia, Italy.

Bruno Frediani (B)

Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy.

Salvatore De Vita (S)

Rheumatology Clinic, Department of Medicine, University of Udine, ASU FC, Udine, Italy.

Roberto Caporali (R)

Division of Rheumatology, ASST Gaetano Pini, Milan, Italy.

Francesco Muratore (F)

Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Marco Sebastiani (M)

Rheumatology Unit, Azienda Ospedaliera Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy.

Carlo Salvarani (C)

Rheumatology Unit, Azienda Ospedaliera Policlinico di Modena, University of Modena and Reggio Emilia, Modena, and Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH